Ducommun Inc

DCO is in a Stage 4 decline after a decisive break below the EMA9/20 and SMA50, activating mean-reversion patterns and tilting the medium-term bias bearish. Price is oversold near the $165–$160 support zone but lacks a confirmed bullish reversal or RSI divergence. The preferred approach is to trim into rallies up into the EMA9/20/SMA50 cluster around $174–$182 for rejection. A failure below $165 would signal deeper mean reversion toward $150–$140.

• ↑Q2 revenue reached $224.5M, marking 5th straight quarter above $200M
• ↑Missile portfolio grew 68% in Q2, driven by PAC-3 contract ramps
• ↓Negative earnings yield and weak profitability factors deter investors